Evofem Biosciences, Inc.
EVFM- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001618835
No open-market purchases or sales by Evofem Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Evofem Biosciences, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 83
- −21 vs. Q1 2021
- Shares held
- 36.2M
- −6.37M (−15.0%) vs. Q1 2021
- Total value
- $40.9M
- −$33.6M (−45.1%) vs. Q1 2021
- New holders
- 17
- 20 more added
- Sold out
- 38
- 24 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVFM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 8 | $122.0K |
| Q2 2022 | 44 | $11.6M |
| Q1 2022 | 68 | $6.66M |
| Q4 2021 | 63 | $8.84M |
| Q3 2021 | 72 | $19.8M |
| Q2 2021 | 83 | $40.9M |
| Q1 2021 | 104 | $74.6M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Evofem Biosciences, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −20,389−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −20,490−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −18,859−100.0% | Sold out |
| Game Plan Financial Advisors, LLC | 0 | $0 | 0.00% | −18,500−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −17,513−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,447−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −17,557−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −15,343−100.0% | Sold out |
| Pinnacle Wealth Planning Services, Inc. | 0 | $0 | 0.00% | −11,870−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −11,302−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −8,336−100.0% | Sold out |
| Capital Analysts, LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −6,534−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Canton Hathaway, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −479−100.0% | Sold out |
| Certified Advisory Corp | 0 | $0 | 0.00% | −650−100.0% | Sold out |
| HighMark Wealth Management LLC | 0 | $0 | 0.00% | −460−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |